Shamburg News · 8-K filed Nov 10, 2026, 4:36 PM EST
iBio Reports Q1 Fiscal 2027 Financial Results and Provides Corporate Update
IBIO · iBio, Inc.
- Earnings
- Materiality: high
iBio, Inc. reported unaudited financial results for the first fiscal quarter of 2027, ended September 30, 2026, with revenue of $1,075 thousand compared with $100 thousand a year earlier. The company reported a net loss of $7,551 thousand, or $(0.05) per share basic and diluted, versus a net loss of $5,720 thousand, or $(0.11) per share, in the prior-year quarter. Research and development expenses rose to $6,650 thousand from $3,550 thousand, and the company held about $76.7 million in cash, cash equivalents and debt investments as of September 30, 2026.
Source: SEC EDGAR, Form 8-K, Item 2.02, accession 0001420720-26-000035.
Written from the filing by Shamburg Markets. Figures are as reported by the company.